JustLight pbc Developing Sunflower Rx™, a Breakthrough Medical Device Treatment for Alzheimer's disease

With $2.8M+ seed funding, including Fortune 500 Japanese Corporation, Asahi Kasei, JustLight is preparing for clinical trials ahead of FDA approval.

WASHINGTON, June 30, 2022 /PRNewswire/ -- JustLight, a public benefit corporation, announced today it's launching clinical trials for its medical device, Sunflower Rx, which provides smart photobiomodulation (PBM) treatment for Alzheimer's disease. Photobiomodulation is the medicinal use of red or near-infrared light to heal, repair, and energize cells in our bodies — without negative side effects. Sunflower Rx uses specific wavelengths of near-infrared light to bypass the skull and be directly absorbed by the brain. 

This revolutionary technology designed by JustLight, in partnership with Light Tree Ventures and Kaiyan Medical, aims to be the world's first FDA-cleared safe and effective Alzheimer's medical device.

"Our patent-pending technology automatically adjusts the LED Light output to replicate clinical parameters, delivering precise and effective photobiomodulation treatment in the comfort of one's home," said JustLight founder Peter Forhan. "We aim to solve the $321 billion Alzheimer's crisis and revolutionize our health care system through universal access to photobiomodulation."

Following a primary investment last year by Fortune 500 Japanese Corporation, Asahi Kasei, JustLight began pilot studies with senior home partner, Nexcare Health Systems, LLC, to better understand possible clinical outcomes of Sunflower use for patients living with Alzheimer's-based dementia. According to Dr. Janet Price, JustLight's Chief Scientific Officer, the pilot program with Nexcare assisted JustLight in identifying possible improvements to the device and routines to better fit customer needs.

"After six weeks of continuous Sunflower use, Nexcare participants reported positive experiences and showed improved or stable cognition scores based on standard clinical measures," Price said. "The majority of mild-moderate individuals experienced an improvement in standardized cognitive test scores in one month of daily use. Participants had improved mood, better communication with staff, and one individual stopped being a fall risk."

JustLight is also making strides with additional company products like Violet, its far UV-C hand-cleaning device which kills germs. A clinical study is underway at the University of Michigan, Ann Arbor.

"We have begun recruitment and subsequent clinical evaluation of Violet at the University of Michigan Hospital," Forhan said. "We expect the completion of this clinical study to be a major step towards earning FDA clearance for UV-C hand sanitation."

Visit http://www.justlight.com/ today learn more.

JustLight pbc Media Contact: 
Jake Serwer / jake@espressopublicrelations.com or Press@justlight.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/justlight-pbc-developing-sunflower-rx-a-breakthrough-medical-device-treatment-for-alzheimers-disease-301578854.html

SOURCE JustLight pbc

Posted In: New Products/ServicesPress Releases

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.